Develops SRA®, an automated ECG analysis method for detecting paroxysmal atrial fibrillation

apoplex medical technologies GmbH

Pirmasens (Delaware Avenue 1-3, 66953)New on Amplifa

2004Founded

20Employees

GmbHLegal form

About apoplex medical technologies

apoplex medical technologies GmbH was founded in 2004 in Pirmasens and develops products for stroke prevention. Its core product is the Stroke Risk Analysis (SRA®), an automated ECG analysis method that detects patients with paroxysmal atrial fibrillation and determines the risk of paroxysmal atrial fibrillation, even when no fibrillation episode is currently occurring. The ECG is automatically recorded via the patient monitor or a long-term ECG recorder, transmitted via an encrypted connection to an analysis server and analyzed there. The analysis report is delivered as a PDF; reports indicating manifest atrial fibrillation undergo cardiological review, which is provided within 24 hours. The variants SRA®clinic for the hospital sector as well as SRA®doc and SRA®24 for office-based physicians are available, complemented by SRA®2go, hSRA (Holter recorder combination) and the SRA® Viewer. According to the company, more than 200 hospitals worldwide use the system, including around 40% of the Stroke Units in Germany; more than 112,000 patients are diagnosed per year. Customers include Klinikum Mittelbaden, Klinikum Saarbrücken and Elblandklinikum Meißen.

Site: Pirmasens
Processes: Automated ECG analysis (SRA®), Analysis report as PDF within 24 hours, Cardiological review/assessment, SRA® Viewer, SRA®clinic, SRA®doc, SRA®24, SRA®2go, hSRA (Holter recorder combination)
Materials: SRA® Stroke Risk Analysis, SRA®clinic, SRA®doc, SRA®24, SRA®2go, hSRA, SRA® Viewer
Certificates: ISO 13485, ISO 27001
Founded: 2004
Employees: 20
Industries: Medical technology / Electromedicine, Stroke prevention, Neurology, Cardiology, Hospitals / Stroke Units, Office-based physicians

01
ECG recording via patient monitor or long-term ECG recorder
02
Encrypted data transmission to the analysis server
03
Automated ECG analysis (SRA®)
04
Analysis report as PDF
05
Cardiological review in case of indication of manifest atrial fibrillation

Methods and Software

SRA®

SRA® Stroke Risk Analysis

Automated ECG analysis method for detecting paroxysmal atrial fibrillation and determining the pAF risk.

SRA®clinic

Variant of the analysis method for the hospital sector, e.g. Stroke Units.

SRA®doc

Variant for office-based physicians.

SRA®24

Variant for office-based physicians.

SRA®2go

All-in-one package, among other things promoted as part of a co-promotion with Bristol-Myers Squibb.

hSRA

Combination of Holter recorder and SRA®; in studies the pAF detection rate doubled (9.7% vs. 4.3% with CEM) at one third of the analysis time.

SRA® Viewer

Software for detailed display of any recorded hours, including Lorenz plot display and display of two ECG channels.

Locations

Pirmasens

Headquarters

Industries

Medical technology / ElectromedicineStroke preventionNeurologyCardiologyHospitals / Stroke UnitsOffice-based physiciansHealth insurance funds

Additional services

Automated ECG analysis (SRA®)Analysis report as PDF within 24 hoursCardiological review/assessmentSRA® ViewerSRA®clinic, SRA®doc, SRA®24, SRA®2gohSRA (Holter recorder combination)

Reference customers

Klinikum MittelbadenKlinikum SaarbrückenElblandklinikum MeißenKlinikum der Stadt Ludwigshafen am Rhein gGmbHBristol-Myers Squibb (co-promotion)Kaufmännische Krankenkasse (pilot project BesV contract NRW)

Certifications

The company is certified according to ISO 13485; in addition, it holds ISO 27001 certification for information security. The accessibility of the ECG data transmission is ensured via encrypted and secured connections.

Evidence	Pirmasens
ISO 13485
ISO 27001

History

2004
Company founded in Pirmasens
2018
Klinikum Mittelbaden uses SRA® on its Stroke Unit